---매수대상---/미국 스몰캡 주당 10불 이하 ADMA 2040FACTORY 2021. 1. 29. 15:48 NAS_ADMA.pdf 0.19MB PSR 5배 정도 목표주가 평균 8 면역 폐렴 ADMA Biologics, Inc. (ADMA) ADMA Biologics, Inc. Discover ADMA Biologics Patented Immunotechnology* Designed for the Immunocompromised We manufacture, develop and commercialize specialized, targeted, plasma-derived therapeutics to extend and enhance the lives of individuals who are naturally or medically www.admabiologics.com ADMA Corporate Deck 11092020.pdf 9.86MB 728x90
